American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 112-121 , July 2009

Decreased Antibody Response to Influenza Vaccination in Kidney Transplant Recipients: A Prospective Cohort Study

  • Kelly A. Birdwell, MD, MSCI

      Affiliations

    • Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Mine R. Ikizler, MS

      Affiliations

    • Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Edith C. Sannella, MT

      Affiliations

    • Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Li Wang, MS

      Affiliations

    • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Daniel W. Byrne, MS

      Affiliations

    • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • T. Alp Ikizler, MD

      Affiliations

    • Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Peter F. Wright, MD

      Affiliations

    • Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN
    • Division of Infectious Disease and International Health, Dartmouth Medical School, Lebanon, NH
    • Corresponding Author InformationAddress correspondence to Peter F. Wright, MD, Dartmouth Medical School, Division of Infectious Disease and International Health, 1 Medical Center Dr, Lebanon, NH 03756

Received 12 June 2008 ,Accepted 30 September 2008.

References 

  1. Kotton CN, Fishman JA. Viral infection in the renal transplant recipient. J Am Soc Nephrol. 2005;16:758–1774
  2. Vilchez RA, Fung J, Kusne S. The pathogenesis and management of influenza virus infection in organ transplant recipients. Transpl Infect Dis. 2002;4:177–182
  3. Fiore AE, Shay DK, Haber P, et al. Prevention and control of influenza (Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007). MMWR Recomm Rep. 2007;56(RR-6):1–54
  4. Carroll RN, Marsh SD, O'Donoghue EP, Breeze DC, Shackman R. Response to influenza vaccine by renal transplant patients. Br Med J. 1974;2:701–703
  5. Pabico RC, Douglas RG, Betts RF, McKenna BA, Freeman RB. Antibody response to influenza vaccination in renal transplant patients: Correlation with allograft function. Ann Intern Med. 1976;85:431–436
  6. Stiver HG, Graves P, Meiklejohn G, Schroter G, Eickhoff TC. Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients. Infect Immun. 1977;16:738–741
  7. Kumar SS, Ventura AK, VanderWerf B. Influenza vaccination in renal transplant recipients. JAMA. 1978;239:840–842
  8. Briggs WA, Rozek RJ, Migdal SD, et al. Influenza vaccination in kidney transplant recipients: Cellular and humoral immune responses. Ann Intern Med. 1980;92:471–477
  9. Huang KL, Armstrong JA, Ho M. Antibody response after influenza immunization in renal transplant patients receiving cyclosporin A or azathioprine. Infect Immun. 1983;40:421–424
  10. Versluis DJ, Beyer WE, Masurel N, Wenting GJ, Weimar W. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation. 1986;42:376–379
  11. Sanchez-Fructuoso AI, Prats D, Naranjo P, et al. Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: Mycophenolate versus azathioprine. Transplantation. 2000;69:436–439
  12. Foley RN, Collins AJ. End-stage renal disease in the United States: An update from the United States Renal Data System. J Am Soc Nephrol. 2007;18:2644–2648
  13. Schwartz B, Martin SW. Principles and Practice of Pediatric Infectious Diseases. In:  Long SS editors. Principles of epidemiology and public health. (ed 3). Philadelphia, PA: Elsevier; 2008;
  14. European Committee for Proprietary Medicinal Products. Note for Guidance on Harmonization of Requirements for Influenza Vaccines, March 1997 (CPMP/BWP/214/96). Brussels, Belgium: European Agency for the Evaluation of Medicinal Products; 1997;
  15. Fox JP, Hall CE, Cooney MK, Foy HM. Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol. 1982;116:212–227
  16. Warburton MF. Immunization against influenza. Med J Aust. 1972;1:546–547
  17. Rudenko LG, Slepushkin AN, Monto AS, et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis. 1993;168:881–887
  18. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  19. Kendal AP, Skehel JJ, Pereira MS. Concepts and Procedures for Laboratory-Based Influenza Surveillance. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control; 1982;
  20. Peters DH, Fitton A, Plosker GL, Faulds D. Tacrolimus (A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation). Drugs. 1993;46:746–794
  21. US Organ Procurement and Transplantation Network (OPTN) and the Scientific Registry of Transplant Recipients (SRTR). 2007 Annual Report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006. Rockville, MD: Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2007;
  22. Hardinger KL, Schnitzler MA, Miller B, et al. Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation. 2004;78:136–141
  23. Kirk AD. Induction immunosuppression. Transplantation. 2006;82:593–602
  24. Keshtkar-Jahromi M, Argani H, Rahnavardi M, et al. Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: A controlled trial. Am J Nephrol. 2008;28:654–660
  25. Scharpe J, Evenepoel P, Maes B, et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant. 2008;8:332–337
  26. Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics. 2005;115:1039–1047
  27. Neuzil KM, Jackson LA, Nelson J, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis. 2006;194:1032–1039
  28. Edwards KM, Dupont WD, Westrich MK, Plummer WD, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis. 1994;169:68–76
  29. Hoskins TW, Davies JR, Smith AJ, Allchin A, Miller CL, Pollock TM. Influenza at Christ's Hospital: March, 1974. Lancet. 1976;1:105–108
  30. Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine. 1997;15:1114–1122
  31. Dinits-Pensy M, Forrest GN, Cross AS, Hise MK. The use of vaccines in adult patients with renal disease. Am J Kidney Dis. 2005;46:997–1011
  32. Osanloo EO, Berlin BS, Popli S, et al. Antibody responses to influenza vaccination in patients with chronic renal failure. Kidney Int. 1978;14:614–618
  33. Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, Collins AJ. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int. 2003;63:738–743

 Originally published online as doi: 10.1053/j.ajkd.2008.09.023 on January 30, 2009.

PII: S0272-6386(08)01608-9

doi: 10.1053/j.ajkd.2008.09.023

American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 112-121 , July 2009

Article Tools

* Image Usage & Resolution